Dexcom (DXCM) Short-term Investments (2010 - 2026)

Dexcom (DXCM) has reported Short-term Investments for 17 consecutive years, with $842.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short-term Investments fell 52.44% year-over-year to $842.0 million in Q2 2026; TTM through Jun 2026 was $842.0 million, a 52.44% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 45.22% from the prior year.
• Short-term Investments was $842.0 million for Q2 2026 at Dexcom, down from $1.3 billion in the prior quarter.
• Over five years, Short-term Investments peaked at $2.6 billion in Q3 2023 and troughed at $842.0 million in Q2 2026.
• A 5-year average of $1.8 billion and a median of $1.9 billion in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 55.13% in 2023 and plunged 52.44% in 2026, its largest moves.
• Over 5 years, Short-term Investments stood at $1.8 billion in 2022, then rose by 18.96% to $2.2 billion in 2023, then dropped by 8.55% to $2.0 billion in 2024, then sank by 45.22% to $1.1 billion in 2025, then fell by 22.11% to $842.0 million in 2026.
• The last three Short-term Investments figures came in at $842.0 million (Q2 2026), $1.3 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.